Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Gait analysis with wearables predicts conversion to Parkinson's disease.

Del Din S, Elshehabi M, Galna B, Hobert M, Warmerdam E, Suenkel U, Brockmann K, Metzger F, Hansen C, Berg D, Rochester L, Maetzler W.

Ann Neurol. 2019 Jul 11. doi: 10.1002/ana.25548. [Epub ahead of print]

PMID:
31294853
2.

Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease.

Schaeffer E, Busch JH, Roeben B, Otterbein S, Saraykin P, Leks E, Liepelt-Scarfone I, Synofzik M, Elshehabi M, Maetzler W, Hansen C, Andris S, Berg D.

Front Neurol. 2019 Jun 19;10:646. doi: 10.3389/fneur.2019.00646. eCollection 2019.

3.

Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.

Lerche S, Machetanz G, Wurster I, Roeben B, Zimmermann M, Pilotto A, Preische O, Stransky E, Deuschle C, Hauser AK, Schulte C, Lachmann I, Waniek K, Gasser T, Berg D, Maetzler W, Brockmann K.

Mov Disord. 2019 Jun 12. doi: 10.1002/mds.27731. [Epub ahead of print]

PMID:
31189032
4.

Functional movement disorders in neurogeriatric inpatients : Underdiagnosed, often comorbid to neurodegenerative disorders and treatable.

Mätzold S, Geritz J, Zeuner KE, Berg D, Paschen S, Hieke J, Sablowsky S, Ortlieb C, Bergmann P, Hofmann W, Espay AJ, Maetzler W.

Z Gerontol Geriatr. 2019 Jul;52(4):324-329. doi: 10.1007/s00391-019-01562-y. Epub 2019 May 28. Review.

PMID:
31139963
5.

Dual vs. Single Tasking During Circular Walking: What Better Reflects Progression in Parkinson's Disease?

Micó-Amigo ME, Kingma I, Heinzel S, Nussbaum S, Heger T, van Lummel RC, Berg D, Maetzler W, van Dieën JH.

Front Neurol. 2019 May 14;10:372. doi: 10.3389/fneur.2019.00372. eCollection 2019.

6.

Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network.

Lieb W, Jacobs G, Wolf A, Richter G, Gaede KI, Schwarz J, Arnold N, Böhm R, Buyx A, Cascorbi I, Franke A, Glinicke C, Held-Feindt J, Junker R, Kalthoff H, Kramer HH, Leypoldt F, Maass N, Maetzler W, May S, Mehdorn HM, Röcken C, Schafmayer C, Schrappe M, Schreiber S, Sebens S, Stephani U, Synowitz M, Weimer J, Zabel P, Nöthlings U, Röder C, Krawczak M.

J Community Genet. 2019 Mar 29. doi: 10.1007/s12687-019-00417-8. [Epub ahead of print]

PMID:
30927239
7.

A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies.

Espay AJ, Hausdorff JM, Sánchez-Ferro Á, Klucken J, Merola A, Bonato P, Paul SS, Horak FB, Vizcarra JA, Mestre TA, Reilmann R, Nieuwboer A, Dorsey ER, Rochester L, Bloem BR, Maetzler W; Movement Disorder Society Task Force on Technology.

Mov Disord. 2019 May;34(5):657-663. doi: 10.1002/mds.27671. Epub 2019 Mar 22. Review.

PMID:
30901495
8.

The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Vizcarra JA, Sánchez-Ferro Á, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, Bonato P, Tan AH, Bloem BR, Kopil C, Daeschler M, Bataille L, Kleiner G, Cedarbaum JM, Klucken J, Merola A, Goetz CG, Stebbins GT, Espay AJ; MDS Technology Task Force and the MDS Rating Scales Program Electronic Development Ad-Hoc Committee.

Mov Disord. 2019 May;34(5):676-681. doi: 10.1002/mds.27673. Epub 2019 Mar 22. No abstract available.

PMID:
30901492
9.

Potential Markers of Progression in Idiopathic Parkinson's Disease Derived From Assessment of Circular Gait With a Single Body-Fixed-Sensor: A 5 Year Longitudinal Study.

Micó-Amigo ME, Kingma I, Heinzel S, Rispens SM, Heger T, Nussbaum S, van Lummel RC, Berg D, Maetzler W, van Dieën JH.

Front Hum Neurosci. 2019 Feb 19;13:59. doi: 10.3389/fnhum.2019.00059. eCollection 2019.

10.

Progressive Gait Deficits in Parkinson's Disease: A Wearable-Based Biannual 5-Year Prospective Study.

Hobert MA, Nussbaum S, Heger T, Berg D, Maetzler W, Heinzel S.

Front Aging Neurosci. 2019 Feb 13;11:22. doi: 10.3389/fnagi.2019.00022. eCollection 2019.

11.

Less Is More - Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined Settings.

Kroneberg D, Elshehabi M, Meyer AC, Otte K, Doss S, Paul F, Nussbaum S, Berg D, Kühn AA, Maetzler W, Schmitz-Hübsch T.

Front Aging Neurosci. 2019 Jan 21;10:435. doi: 10.3389/fnagi.2018.00435. eCollection 2018.

12.

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W, Marras C.

Front Neurol. 2018 Dec 21;9:1123. doi: 10.3389/fneur.2018.01123. eCollection 2018.

13.

Moderate Frequency Resistance and Balance Training Do Not Improve Freezing of Gait in Parkinson's Disease: A Pilot Study.

Schlenstedt C, Paschen S, Seuthe J, Raethjen J, Berg D, Maetzler W, Deuschl G.

Front Neurol. 2018 Dec 10;9:1084. doi: 10.3389/fneur.2018.01084. eCollection 2018.

14.

Fall Risk in Relation to Individual Physical Activity Exposure in Patients with Different Neurodegenerative Diseases: a Pilot Study.

Srulijes K, Klenk J, Schwenk M, Schatton C, Schwickert L, Teubner-Liepert K, Meyer M, K C S, Maetzler W, Becker C, Synofzik M.

Cerebellum. 2019 Jun;18(3):340-348. doi: 10.1007/s12311-018-1002-x.

PMID:
30617629
15.

How Mobile Health Technology and Electronic Health Records Will Change Care of Patients with Parkinson's Disease.

Hansen C, Sanchez-Ferro A, Maetzler W.

J Parkinsons Dis. 2018;8(s1):S41-S45. doi: 10.3233/JPD-181498.

16.

Prodromal features of Parkinson's disease: Self-reported symptoms versus clinically assessed signs.

Friederich A, Flinspach A, Suenkel U, Eschweiler GW, Greulich K; TREND study team, Maetzler W, Berg D, Heinzel S.

Mov Disord. 2019 Jan;34(1):144-146. doi: 10.1002/mds.27539. Epub 2018 Nov 13. No abstract available.

PMID:
30423202
17.

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.

Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM; and The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group.

J Parkinsons Dis. 2019;9(1):31-61. doi: 10.3233/JPD-181471.

18.

Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis.

Dos Santos MCT, Scheller D, Schulte C, Mesa IR, Colman P, Bujac SR, Bell R, Berteau C, Perez LT, Lachmann I, Berg D, Maetzler W, Nogueira da Costa A.

PLoS One. 2018 Nov 1;13(11):e0206536. doi: 10.1371/journal.pone.0206536. eCollection 2018.

19.

Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.

Becker S, Bäumer A, Maetzler W, Nussbaum S, Timmers M, Van Nueten L, Salvadore G, Zaunbrecher D, Roeben B, Brockmann K, Streffer J, Berg D, Liepelt-Scarfone I.

J Neuropsychol. 2018 Oct 15. doi: 10.1111/jnp.12173. [Epub ahead of print]

PMID:
30320954
20.

Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis.

Körtvelyessy P, Prüss H, Thurner L, Maetzler W, Vittore-Welliong D, Schultze-Amberger J, Heinze HJ, Reinhold D, Leypoldt F, Schreiber S, Bittner D.

Front Neurol. 2018 Sep 19;9:668. doi: 10.3389/fneur.2018.00668. eCollection 2018.

21.

Parkinson's disease: evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study.

Lerche S, Wurster I, Röben B, Machetanz G, Zimmermann M, Bernhard F, Stransky E, Deuschle C, Schulte C, Hansson O, Zetterberg H, Gasser T, Berg D, Maetzler W, Brockmann K.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):165-170. doi: 10.1136/jnnp-2018-318956. Epub 2018 Sep 25.

PMID:
30254084
22.

Cholinergic Pathway SNPs and Postural Control in 477 Older Adults.

Arnold C, Schulte C, Moscovich M, Sünkel U, Zaunbrecher L, Metzger F, Gasser T, Eschweiler GW, Hauser AK, Berg D, Maetzler W.

Front Aging Neurosci. 2018 Sep 4;10:260. doi: 10.3389/fnagi.2018.00260. eCollection 2018.

23.

[Validation of the Geriatric Check in a cohort of hospitalized neurological patients].

Hobert MA, Bernhard FP, Bettecken K, Sartor J, Maetzler W, Jamour M.

Z Gerontol Geriatr. 2019 Mar;52(2):172-178. doi: 10.1007/s00391-018-1441-5. Epub 2018 Sep 11. German.

PMID:
30206742
24.

Validation of a Lower Back "Wearable"-Based Sit-to-Stand and Stand-to-Sit Algorithm for Patients With Parkinson's Disease and Older Adults in a Home-Like Environment.

Pham MH, Warmerdam E, Elshehabi M, Schlenstedt C, Bergeest LM, Heller M, Haertner L, Ferreira JJ, Berg D, Schmidt G, Hansen C, Maetzler W.

Front Neurol. 2018 Aug 10;9:652. doi: 10.3389/fneur.2018.00652. eCollection 2018.

25.

Arm swing asymmetry in overground walking.

Killeen T, Elshehabi M, Filli L, Hobert MA, Hansen C, Rieger D, Brockmann K, Nussbaum S, Zörner B, Bolliger M, Curt A, Berg D, Maetzler W.

Sci Rep. 2018 Aug 24;8(1):12803. doi: 10.1038/s41598-018-31151-9.

26.

Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.

Lerche S, Liepelt-Scarfone I, Wurster I, Schulte C, Schäffer E, Röben B, Machetanz G, Zimmermann M, Akbas S, Hauser AK, Gasser T, Maetzler W, Berg D, Brockmann K.

Mov Disord. 2018 Aug;33(8):1349-1353. doi: 10.1002/mds.27427. Epub 2018 Aug 22.

PMID:
30132985
27.

Wearables for gait and balance assessment in the neurological ward - study design and first results of a prospective cross-sectional feasibility study with 384 inpatients.

Bernhard FP, Sartor J, Bettecken K, Hobert MA, Arnold C, Weber YG, Poli S, Margraf NG, Schlenstedt C, Hansen C, Maetzler W.

BMC Neurol. 2018 Aug 16;18(1):114. doi: 10.1186/s12883-018-1111-7.

28.

Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD).

Lerche S, Machetanz G, Roeben B, Wurster I, Zimmermann M, von Thaler AK, Liepelt-Scarfone I, Eschweiler GW, Fallgatter A, Metzger F, Maetzler W, Berg D, Brockmann K.

Neurobiol Aging. 2018 Oct;70:242-246. doi: 10.1016/j.neurobiolaging.2018.06.029. Epub 2018 Jun 30.

PMID:
30048891
29.

Brain-Area Specific White Matter Hyperintensities: Associations to Falls in Parkinson's Disease.

Ciliz M, Sartor J, Lindig T, Pilotto A, Schäffer E, Weiss M, Scheltens P, Becker S, Hobert MA, Berg D, Liepelt-Scarfone I, Maetzler W.

J Parkinsons Dis. 2018;8(3):455-462. doi: 10.3233/JPD-181351.

PMID:
30040742
30.

Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?

Heinzel S, Berg D, Binder S, Ebersbach G, Hickstein L, Herbst H, Lorrain M, Wellach I, Maetzler W, Petersen G, Schmedt N, Volkmann J, Woitalla D, Amelung V.

Front Neurol. 2018 Jun 29;9:500. doi: 10.3389/fneur.2018.00500. eCollection 2018.

31.

Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease.

Blum D, la Fougère C, Pilotto A, Maetzler W, Berg D, Reimold M, Liepelt-Scarfone I.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2387-2395. doi: 10.1007/s00259-018-4085-1. Epub 2018 Jul 14.

PMID:
30008111
32.

Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.

Sulzer P, Becker S, Maetzler W, Kalbe E, van Nueten L, Timmers M, Machetanz G, Streffer J, Salvadore G, Scholz E, Tkaczynska Z, Brockmann K, Berg D, Liepelt-Scarfone I.

J Neurol. 2018 Sep;265(9):1976-1984. doi: 10.1007/s00415-018-8942-4. Epub 2018 Jun 23.

PMID:
29936665
33.

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.

Stoessel D, Stellmann JP, Willing A, Behrens B, Rosenkranz SC, Hodecker SC, Stürner KH, Reinhardt S, Fleischer S, Deuschle C, Maetzler W, Berg D, Heesen C, Walther D, Schauer N, Friese MA, Pless O.

Front Hum Neurosci. 2018 Jun 4;12:226. doi: 10.3389/fnhum.2018.00226. eCollection 2018.

34.

[Therapy of Dementia: State of the Art].

Roeben B, Zieschang T, Maetzler W.

Dtsch Med Wochenschr. 2018 May;143(10):741-747. doi: 10.1055/s-0043-113619. Epub 2018 May 4. German.

PMID:
29727890
35.

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.

Dos Santos MCT, Barreto-Sanz MA, Correia BRS, Bell R, Widnall C, Perez LT, Berteau C, Schulte C, Scheller D, Berg D, Maetzler W, Galante PAF, Nogueira da Costa A.

Oncotarget. 2018 Apr 3;9(25):17455-17465. doi: 10.18632/oncotarget.24736. eCollection 2018 Apr 3.

36.

Effect of Fear of Falling on Turning Performance in Parkinson's Disease in the Lab and at Home.

Haertner L, Elshehabi M, Zaunbrecher L, Pham MH, Maetzler C, van Uem JMT, Hobert MA, Hucker S, Nussbaum S, Berg D, Liepelt-Scarfone I, Maetzler W.

Front Aging Neurosci. 2018 Mar 27;10:78. doi: 10.3389/fnagi.2018.00078. eCollection 2018.

37.

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.

Stoessel D, Schulte C, Teixeira Dos Santos MC, Scheller D, Rebollo-Mesa I, Deuschle C, Walther D, Schauer N, Berg D, Nogueira da Costa A, Maetzler W.

Front Aging Neurosci. 2018 Mar 5;10:51. doi: 10.3389/fnagi.2018.00051. eCollection 2018.

38.

Are Hypometric Anticipatory Postural Adjustments Contributing to Freezing of Gait in Parkinson's Disease?

Schlenstedt C, Mancini M, Nutt J, Hiller AP, Maetzler W, Deuschl G, Horak F.

Front Aging Neurosci. 2018 Feb 15;10:36. doi: 10.3389/fnagi.2018.00036. eCollection 2018.

39.

What is Functional Mobility Applied to Parkinson's Disease?

Bouça-Machado R, Maetzler W, Ferreira JJ.

J Parkinsons Dis. 2018;8(1):121-130. doi: 10.3233/JPD-171233.

40.

[Influence of computer-based cognitive training on mobility in healthy older adults : A systematic review].

Geritz J, Maetzler W, Schlenstedt C.

Z Gerontol Geriatr. 2018 Feb;51(2):184-192. doi: 10.1007/s00391-018-1369-9. Epub 2018 Jan 23. German.

PMID:
29362878
41.

Effect of physical activity on cognitive flexibility, depression and RBD in healthy elderly.

Lerche S, Gutfreund A, Brockmann K, Hobert MA, Wurster I, Sünkel U, Eschweiler GW, Metzger FG, Maetzler W, Berg D.

Clin Neurol Neurosurg. 2018 Feb;165:88-93. doi: 10.1016/j.clineuro.2018.01.008. Epub 2018 Jan 9.

PMID:
29331872
42.

The association between objectively measured physical activity, depression, cognition, and health-related quality of life in Parkinson's disease.

van Uem JMT, Cerff B, Kampmeyer M, Prinzen J, Zuidema M, Hobert MA, Gräber S, Berg D, Maetzler W, Liepelt-Scarfone I.

Parkinsonism Relat Disord. 2018 Mar;48:74-81. doi: 10.1016/j.parkreldis.2017.12.023. Epub 2017 Dec 23.

PMID:
29307560
43.

Parkinson disease in 2017: Changing views after 200 years of Parkinson disease.

Maetzler W, Berg D.

Nat Rev Neurol. 2018 Feb;14(2):70-72. doi: 10.1038/nrneurol.2017.183. Epub 2018 Jan 5. No abstract available.

PMID:
29302062
44.

SNPs in Aβ clearance proteins: Lower CSF Aβ1-42 levels and earlier onset of dementia in PD.

Brockmann K, Lerche S, Dilger SS, Stirnkorb JG, Apel A, Hauser AK, Liepelt-Scarfone I, Berg D, Gasser T, Schulte C, Maetzler W.

Neurology. 2017 Dec 5;89(23):2335-2340. doi: 10.1212/WNL.0000000000004705. Epub 2017 Nov 8.

PMID:
29117956
45.

Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.

Lerche S, Schulte C, Srulijes K, Pilotto A, Rattay TW, Hauser AK, Stransky E, Deuschle C, Csoti I, Lachmann I, Zetterberg H, Liepelt-Scarfone I, Gasser T, Maetzler W, Berg D, Brockmann K.

Mov Disord. 2017 Dec;32(12):1780-1783. doi: 10.1002/mds.27199. Epub 2017 Nov 2.

PMID:
29094781
46.

Corrigendum: White Matter Changes-Related Gait and Executive Function Deficits: Associations with Age and Parkinson's Disease.

Sartor J, Bettecken K, Bernhard FP, Hofmann M, Gladow T, Lindig T, Ciliz M, Ten Kate M, Geritz J, Heinzel S, Benedictus M, Scheltens P, Hobert MA, Maetzler W.

Front Aging Neurosci. 2017 Oct 17;9:342. doi: 10.3389/fnagi.2017.00342. eCollection 2017.

47.

Dementia with Lewy bodies: cerebrospinal fluid suppresses neuronal network activity.

Theiss S, Maetzler W, Deuschle C, Lerche H, Koch H, Dihné M.

Neuroreport. 2017 Nov 8;28(16):1061-1065. doi: 10.1097/WNR.0000000000000890.

PMID:
28953602
48.

Validation of a Step Detection Algorithm during Straight Walking and Turning in Patients with Parkinson's Disease and Older Adults Using an Inertial Measurement Unit at the Lower Back.

Pham MH, Elshehabi M, Haertner L, Del Din S, Srulijes K, Heger T, Synofzik M, Hobert MA, Faber GS, Hansen C, Salkovic D, Ferreira JJ, Berg D, Sanchez-Ferro Á, van Dieën JH, Becker C, Rochester L, Schmidt G, Maetzler W.

Front Neurol. 2017 Sep 4;8:457. doi: 10.3389/fneur.2017.00457. eCollection 2017.

49.

Progression of prodromal motor and non-motor symptoms in the premotor phase study - 2-year follow-up data.

Liepelt-Scarfone I, Brändle B, Yilmaz R, Gauss K, Schaeffer E, Timmers M, Wurster I, Brockmann K, Maetzler W, Van Nueten L, Streffer JR, Berg D.

Eur J Neurol. 2017 Nov;24(11):1369-1374. doi: 10.1111/ene.13397. Epub 2017 Sep 5.

PMID:
28872736
50.

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.

Trezzi JP, Galozzi S, Jaeger C, Barkovits K, Brockmann K, Maetzler W, Berg D, Marcus K, Betsou F, Hiller K, Mollenhauer B.

Mov Disord. 2017 Oct;32(10):1401-1408. doi: 10.1002/mds.27132. Epub 2017 Aug 26.

PMID:
28843022

Supplemental Content

Loading ...
Support Center